RIG
35
-3
TGT
50
2
MPC
44
3
EA
44
-2
NFLX
55
-3
ADSK
65
-2
AAL
47
-3
WYNN
34
-3
MAR
50
3
DRI
64
4
PM
52
-4
D
55
-6
DLTR
31
3
CCL
71
4
AEP
59
-3
VFC
57
4
M
14
2
VZ
45
-2
HSY
38
-2
GOOG
63
2
RIG
35
-3
TGT
50
2
MPC
44
3
EA
44
-2
NFLX
55
-3
ADSK
65
-2
AAL
47
-3
WYNN
34
-3
MAR
50
3
DRI
64
4
PM
52
-4
D
55
-6
DLTR
31
3
CCL
71
4
AEP
59
-3
VFC
57
4
M
14
2
VZ
45
-2
HSY
38
-2
GOOG
63
2
Financhill
Back

Avidity Biosciences 10K Form

Sell
31

RNA
Avidity Biosciences

Last Price:
45.69
Seasonality Move:
-6.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RNA News And Ratings

See the #1 stock for the next 7 days that we like better than RNA

RNA Financial Statistics

Sales & Book Value

Annual Sales: $9.56M
Cash Flow: $-65.54M
Price / Cash Flow: 0
Annual Sales: $11.17
Price / Book: 4.28

Profitability

EPS (TTM): -2.95000
Net Income (TTM): $-252.45M
Gross Margin: $8.9M
Return on Equity: -34.78%
Return on Assets: -30.7%

Avidity Biosciences Earnings Forecast

Key Avidity Biosciences Financial Ratios

  • The Gross Profit Margin over the past 1 years for RNA is 100.00%.
  • The Selling, General & Administrative Expenses for RNA have been equal to 566.84% of Gross Profit Margin.
  • The Research & Development expenses have been 1,997.57% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of RNA is -2,219.87% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 1 years.

Avidity Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RNA
CUSIP: 05370A
Website: aviditybiosciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 15.78
Quick Ratio: 15.61

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RNA Technical Analysis vs Fundamental Analysis

Sell
31
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy or a Sell?